Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients wi...
Q1 2026
May 4, 2026
FY 2025
Mar 2, 2026
Q4 2025
Q3 2025
Nov 3, 2025
Q2 2025
Aug 7, 2025
